David Olson

Co-founder and Chief Innovation Officer at Delix Therapeutics and 1 other company
On the record
Represented by:

Co-founder and Chief Scientific Officer of Delix Therapeutics, a preclinical biotech company developing novel disease-modifying therapeutics for psychiatric and neurological conditions. David's work consists of removing the hallucinogenic side effects of psychedelics medicines while retaining their ability to assist patients with mental health illnesses. David is also a professor at UC Davis.

Recent Quotes
Sign up to view all
  • The idea is that if you can regrow those atrophied neurons, re-establish the synaptic connectivity in the prefrontal cortex, you can kind of exert this top-down control on a lot of behaviours, and improve mood.

    11 June 2021
Sign up to view all